WASHINGTON — The pharmaceutical industry deployed its top guns to Capitol Hill on Wednesday as senators pushed to find consensus on a major package of drug pricing reforms.
Spotted in the Senate basement at lunchtime: Stephen Ubl, the head of the industry lobbying organization PhRMA, and Dr. Giovanni Caforio, the CEO of Bristol Myers-Squibb.
